Institution
German Cancer Research Center
Recent research
- BiologyOpen access
Integrated metabolomics data analysis to generate mechanistic hypotheses with MetaProViz
ABSTRACT With the growing number of metabolomics and lipidomics studies, robust strategies for bioinformatic analyses are increasingly important. However, the absence of standardized and reproducible workflows, coupled with ambiguous metabolite annotations, hampers effective anal...
- Health & MedicineOpen access
Molecular characterization of mismatch repair deficient tumors in young Jordanian patients
<title>Abstract</title> In Jordan, approximately 19% of colorectal carcinomas (CRCs) in patients younger than 45 years show mismatch repair deficiency (MMRD) by immunohistochemistry (IHC). MMRD in pediatric high-grade gliomas (HGG) and CRC in Jordan appears substantially more fre...
- Health & MedicineOpen access
Background/Objectives: High linear energy transfer (LET) carbon ions achieved more effective and biologically robust tumor control than photons in preclinical prostate cancer models; however, the longitudinal development of histopathological parameters remains insufficiently char...
- BiologyOpen access
Triple-negative breast cancer (TNBC) accounts for 10–15% of newly diagnosed breast cancer, and its aetiology is poorly understood compared to other breast cancer subtypes. We applied untargeted metabolomics to identify novel biological pathways associated with TNBC risk and poten...
- Physics & SpaceOpen access
Purpose In breast radiotherapy, delivery of manually-calculated electron boosts limits retrospective dose–response analyses as dose distribution is unavailable. This work evaluates the feasibility of reconstructing dose distributions from manually planned electron boosts in breas...
- Health & MedicineOpen access
Abstract To externally validate the RSNA 2020 challenge 2 nd -place deep-learning (DL) algorithm for detecting pulmonary embolism (PE) on computed tomography pulmonary angiography (CTPA) scans with additional focus on subsegmental-only PEs (SSPE). Between 2015 and 2022 1,038 CTPA...
- Health & MedicineOpen access
Abstract Ewing sarcoma is a rare, fusion-driven malignancy with poor prognosis in the metastatic setting, for which no established immunotherapeutic treatment is currently available. Fusion breakpoints are rational precision immunotherapy targets, yet clinical evidence of immunog...
- Health & Medicine
Accelerating Translation of NK Cell Therapies to the Clinic: A European Perspective
Adoptive immunotherapies have emerged as a promising strategy in the treatment of hematological malignancies. To date, seven chimeric antigen receptor (CAR)-T cell products have obtained market authorization in Europe for B-cell malignancies, where they have revolutionized treatm...
- Health & MedicineOpen access
Background Epstein-Barr virus (EBV) is strongly implicated in the development of multiple sclerosis (MS) but whether EBV-related immune responses are also relevant for disease progression after diagnosis remains unclear. We investigated whether Epstein-Barr nuclear antigen 1 (EBN...